» Articles » PMID: 12930575

Luteinizing Hormone Affects Uterine Receptivity Independently of Ovarian Function

Overview
Publisher Elsevier
Date 2003 Aug 22
PMID 12930575
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies have suggested that LH, in addition to its well-known effects on the ovary, may exert direct effects on the uterus. This study evaluated the effects of mid-cycle administration of human chorionic gonadotrophin (HCG), which signals through the LH receptor, on endometrial thickness and uterine receptivity in two groups of women lacking ovarian activity and receiving embryos from an oocyte donation programme. Patients in one group still had ovulatory cycles, but their ovarian function was suppressed by pituitary down-regulation with a gonadotrophin-releasing hormone (GnRH) agonist in the embryo transfer cycle, resulting in low endogenous LH concentrations. Patients in the other group were menopausal women whose pituitary function was not down-regulated in the embryo transfer cycle and whose endogenous LH concentrations were thus high. Patients in each of the two groups were randomized into two subgroups. Patients in one subgroup were given 5000 IU of HCG 2 days before oocyte recovery in the corresponding donor. Patients in the other subgroup received placebo at the same time. Oocytes from each donor were randomly distributed between one patient from the HCG subgroup and one patient from the placebo subgroup in each patient group. Endometrial growth and secretory transformation were stimulated by sequential treatment with oestradiol valerate and progesterone. In women with low endogenous LH receiving placebo, endometrial thickness stopped increasing at the beginning of secretory transformation. Mid-cycle HCG administration resulted in a continuous increase in endometrial thickness through this period, improved the implantation rate after embryo transfer in these women (30.6 versus 20.7%) and augmented the number of multiple pregnancies. No similar stagnation of endometrial thickness and no effects of mid-cycle HCG administration on endometrial thickness, the implantation rate and the number of multiple pregnancies were found in women with high endogenous LH. It is concluded that endometrial maturation is disturbed in women with low endogenous LH but can be rescued by mid-cycle stimulation of LH receptor with exogenous HCG in the absence of ovarian activity.

Citing Articles

The role of recombinant LH in ovarian stimulation: what's new?.

Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P Reprod Biol Endocrinol. 2025; 23(Suppl 1):38.

PMID: 40059197 PMC: 11892182. DOI: 10.1186/s12958-025-01361-8.


Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study.

Liang Y, Hou X, Chen H, Yang R, Wang R, Mao R Int J Womens Health. 2024; 16:1103-1111.

PMID: 38895039 PMC: 11185249. DOI: 10.2147/IJWH.S454410.


Safety profiles of offspring born from early-follicular long-acting GnRH agonist protocol and daily mid-luteal GnRH agonist protocol: a retrospective study.

Du L, Song J, Fan W, Ye T, Kong H BMC Pregnancy Childbirth. 2024; 24(1):393.

PMID: 38807043 PMC: 11134633. DOI: 10.1186/s12884-024-06589-7.


Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus.

Salehpour S, Aleyasin A, Moini A, Mousavifar N, Mohammadhossein N, Abdollahi Fard S Front Reprod Health. 2024; 6:1397446.

PMID: 38784124 PMC: 11111922. DOI: 10.3389/frph.2024.1397446.


Effect of intramuscular injection of human chorionic gonadotropin on endometrium preparation in frozen-thawed embryo transfer cycle: A randomized clinical trial.

Akbari Asbagh F, Ghasemzadeh F, Ebrahimi M, Davari-Tanha F, Feizabad E, Akbari Asbagh P Caspian J Intern Med. 2023; 14(2):185-191.

PMID: 37223296 PMC: 10201127. DOI: 10.22088/cjim.14.2.185.